Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Ford

Showing results (41-50 of 207) with videos related to

Pageof 21
Sort By:
The Journal of Biological Chemistry|August 29, 2003
In vivo recruitment of XPC to UV-induced cyclobutane pyrimidine dimers by the DDB2 gene productMaureen E Fitch, Satoshi Nakajima, Akira Yasui, et al.
Health Affairs (Project Hope)|May 8, 2018
Strategies For Clinical Implementation: Precision Oncology At Three Distinct InstitutionsLincoln D Nadauld, James M Ford, Daryl Pritchard, et al.
Cancer Research|April 9, 2009
Defective repair of oxidative dna damage in triple-negative breast cancer confers sensitivity to inhibition of poly(ADP-ribose) polymeraseElizabeth Alli, Vandana B Sharma, Preethi Sunderesakumar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 14, 2013
A young woman with bilateral breast cancer: identifying a genetic cause and implications for managementMonique A de Bruin, James M Ford, Allison W Kurian
Cancer Genetics|March 14, 2022
Somatic tumor testing implications for Lynch syndrome germline genetic testingKathleen Barrus, Natasha Purington, Nicolette Chun, et al.
JNCI Cancer Spectrum|April 8, 2020
Germline Testing for Patients With <i>BRCA1/2</i> Mutations on Somatic Tumor TestingKatherine Vlessis, Natasha Purington, Nicolette Chun, et al.
Molecular Pharmacology|February 3, 2007
Reversal of stathmin-mediated resistance to paclitaxel and vinblastine in human breast carcinoma cellsElizabeth Alli, Jin-Ming Yang, James M Ford, et al.
Cancer Research|September 14, 2014
Therapeutic targeting of BRCA1-mutated breast cancers with agents that activate DNA repairElizabeth Alli, David Solow-Cordero, Stephanie C Casey, et al.
Journal of the American Chemical Society|July 15, 2016
A Chimeric ATP-Linked Nucleotide Enables Luminescence Signaling of Damage Surveillance by MTH1, a Cancer TargetDebin Ji, Andrew A Beharry, James M Ford, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 10, 2010
Longer relative telomere length in blood from women with sporadic and familial breast cancer compared with healthy controlsMaria M Gramatges, Melinda L Telli, Raymond Balise, et al.
Pageof 21

Showing results (41-50 of 207) with videos related to

Sort By:
Pageof 21
The Journal of Biological Chemistry|August 29, 2003
In vivo recruitment of XPC to UV-induced cyclobutane pyrimidine dimers by the DDB2 gene productMaureen E Fitch, Satoshi Nakajima, Akira Yasui, et al.
Health Affairs (Project Hope)|May 8, 2018
Strategies For Clinical Implementation: Precision Oncology At Three Distinct InstitutionsLincoln D Nadauld, James M Ford, Daryl Pritchard, et al.
Cancer Research|April 9, 2009
Defective repair of oxidative dna damage in triple-negative breast cancer confers sensitivity to inhibition of poly(ADP-ribose) polymeraseElizabeth Alli, Vandana B Sharma, Preethi Sunderesakumar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 14, 2013
A young woman with bilateral breast cancer: identifying a genetic cause and implications for managementMonique A de Bruin, James M Ford, Allison W Kurian
Cancer Genetics|March 14, 2022
Somatic tumor testing implications for Lynch syndrome germline genetic testingKathleen Barrus, Natasha Purington, Nicolette Chun, et al.
JNCI Cancer Spectrum|April 8, 2020
Germline Testing for Patients With <i>BRCA1/2</i> Mutations on Somatic Tumor TestingKatherine Vlessis, Natasha Purington, Nicolette Chun, et al.
Molecular Pharmacology|February 3, 2007
Reversal of stathmin-mediated resistance to paclitaxel and vinblastine in human breast carcinoma cellsElizabeth Alli, Jin-Ming Yang, James M Ford, et al.
Cancer Research|September 14, 2014
Therapeutic targeting of BRCA1-mutated breast cancers with agents that activate DNA repairElizabeth Alli, David Solow-Cordero, Stephanie C Casey, et al.
Journal of the American Chemical Society|July 15, 2016
A Chimeric ATP-Linked Nucleotide Enables Luminescence Signaling of Damage Surveillance by MTH1, a Cancer TargetDebin Ji, Andrew A Beharry, James M Ford, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 10, 2010
Longer relative telomere length in blood from women with sporadic and familial breast cancer compared with healthy controlsMaria M Gramatges, Melinda L Telli, Raymond Balise, et al.
Pageof 21